A&P LIFESCIENCE FUND, FI
•CLASE A
Valor Liquidativo
Patrimonio
Cartera Renta Variable
Activo | Div. | Valor | Peso | Dif. |
---|---|---|---|---|
US45253H1014 ImmunoGen Inc | EUR | 292.471 € | 8.6% | 84.16% |
US38000Q1022 GlycoMimetics Inc | EUR | 235.927 € | 6.93% | 76.57% |
US5324571083 Lilly (Eli) & Co. | EUR | 118.812 € | 3.49% | 61.62% |
US4622221004 Ionis Pharmaceutical | EUR | 114.617 € | 3.37% | 57.57% |
CH0334081137 CRISPR Therapeutics | EUR | 109.617 € | 3.22% | 51.61% |
US05464T1043 Axsome Therapeutics | EUR | 99.929 € | 2.94% | 42.17% |
US48576A1007 Karuna Therapeutics | EUR | 89.170 € | 2.62% | Nueva |
US02043Q1076 Alnylam Pharmaceutic | EUR | 85.483 € | 2.51% | 41.08% |
US04280A1007 Arrowhead Pharmaceut | EUR | 80.277 € | 2.36% | 19.56% |
US92790C1045 Viridian Therapeutic | EUR | 79.532 € | 2.34% | Nueva |
US60468T1051 Mirati Therapeutics | EUR | 77.329 € | 2.27% | 121.73% |
US87164F1057 Descom Inc | EUR | 77.169 € | 2.27% | 32.05% |
US0311621009 Amgen Inc. | EUR | 70.707 € | 2.08% | 63.11% |
US3723032062 Genmab A/S | EUR | 69.253 € | 2.04% | 8.97% |
US00847X1046 Agios Pharmaceutical | EUR | 65.021 € | 1.91% | 6.76% |
US0028241000 Abbott Laboratories | EUR | 64.114 € | 1.88% | 92.08% |
US85205L1070 SpringWorks Therapeu | EUR | 61.004 € | 1.79% | Nueva |
US50127T1097 Kura Oncology Inc | EUR | 59.492 € | 1.75% | 73.43% |
US45166A1025 Ideaya Biosciences I | EUR | 54.535 € | 1.6% | 91.93% |
IE00BTN1Y115 Medtronic INC | EUR | 53.731 € | 1.58% | 92.29% |
US30063P1057 Exact Sciences Corp | EUR | 48.721 € | 1.43% | 2.36% |
US9250501064 Verona Pharma PLC | EUR | 47.417 € | 1.39% | Nueva |
US04335A1051 Arvinas Inc | EUR | 47.055 € | 1.38% | 113.88% |
US4923271013 Keros Therapeutics I | EUR | 45.310 € | 1.33% | 25.35% |
US92686J1060 Viking Therapeutics | EUR | 43.259 € | 1.27% | 60.14% |
US07725L1026 Beigene ltd-adr | EUR | 41.990 € | 1.23% | 25.32% |
US24823R1059 Denali Therapeutics | EUR | 41.213 € | 1.21% | 1.84% |
US28176E1082 Edwards Lifesciences | EUR | 41.030 € | 1.21% | Nueva |
US1011371077 Accs. Boston Scienti | EUR | 41.319 € | 1.21% | 35.28% |
US7291391057 Pliant Therapeutics | EUR | 40.161 € | 1.18% | 24.06% |
US03152W1099 Amicus Therapeutics | EUR | 39.759 € | 1.17% | Nueva |
US67080M1036 Nurix Therapeutics I | EUR | 37.871 € | 1.11% | 26.62% |
US75886F1075 Regeneron Pharmaceut | EUR | 35.803 € | 1.05% | 55.31% |
US00287Y1091 AbbVie Inc | EUR | 35.377 € | 1.04% | 46.14% |
US66987V1098 NOVARTIS AG-REG SHS | EUR | 35.032 € | 1.03% | 27.51% |
US98956P1021 Zimmer Holdings Inc | EUR | 33.735 € | 0.99% | Nueva |
US8835561023 Thermo Electron Corp | EUR | 33.177 € | 0.98% | 30.88% |
US8036071004 Sarepta Therapeutics | EUR | 32.932 € | 0.97% | 6.34% |
US98401F1057 Xencor Inc | EUR | 32.809 € | 0.96% | 9.92% |
US2825591033 89bio Inc | EUR | 31.570 € | 0.93% | Nueva |
US70975L1070 Penumbra Inc | EUR | 30.990 € | 0.91% | 6.42% |
US2358511028 Danaher Corp | EUR | 30.806 € | 0.91% | Nueva |
US2300311063 Cullinan Oncology In | EUR | 29.077 € | 0.85% | Nueva |
US09061G1013 Biostar Pharmaceutic | EUR | 28.736 € | 0.84% | 40.72% |
US00445A1007 ACELYRIN Inc | EUR | 28.032 € | 0.82% | 51.23% |
US7711951043 ROCHE HOLDING | EUR | 27.799 € | 0.82% | 22.51% |
US7611521078 Resmed Inc | EUR | 27.582 € | 0.81% | Nueva |
US6031701013 Mineralys Therapeuti | EUR | 25.179 € | 0.74% | Nueva |
US15117B2025 Celldex Therapeutics | EUR | 24.862 € | 0.73% | Nueva |
US00973Y1082 Akero Therapeutics I | EUR | 22.633 € | 0.67% | Nueva |
US36266G1076 GE HealthCare Techno | EUR | 20.943 € | 0.62% | Nueva |
US8808811074 Terns Pharmaceutical | EUR | 20.924 € | 0.61% | Nueva |
US09627Y1091 Blueprint Medicines | EUR | 19.803 € | 0.58% | Nueva |
US80105N1054 Sanofi (Eff Aquitain | EUR | 19.326 € | 0.57% | Nueva |
US6418711080 Ambrx Biopharma Inc | EUR | 18.421 € | 0.54% | Nueva |
US0758871091 Accs. Becton Dickins | EUR | 17.008 € | 0.5% | Nueva |
US92337C2035 Verastem Inc | EUR | 16.377 € | 0.48% | Nueva |
US40131M1099 Guardant Health Inc | EUR | 15.879 € | 0.47% | 4.51% |
US19240Q2012 Cogent Biosciences I | EUR | 15.633 € | 0.46% | Nueva |
US89422G1076 Travere Therapeutics | EUR | 15.025 € | 0.44% | 19.89% |
US5015751044 Kymera Therapeutics | EUR | 12.431 € | 0.37% | Nueva |
US92338C1036 Veralto Corp | EUR | 3651 € | 0.11% | Nueva |
US7999261008 Sandoz Group AG | EUR | 2204 € | 0.06% | Nueva |
US75082Q1058 Rain Oncology Inc | EUR | 0 € | 0% | Vendida |
US16961L1061 Chinook Therapeutics | EUR | 0 € | 0% | Vendida |
US68236P1075 Oncternal Therapeuti | EUR | 0 € | 0% | Vendida |
US59045L1061 Mersana Therapeutics | EUR | 0 € | 0% | Vendida |
US0076244062 Advaxis Inc | EUR | 0 € | 0% | Vendida |
US4497781090 IO Biotech Inc | EUR | 0 € | 0% | Vendida |
US03890D1081 Aravive Inc | EUR | 0 € | 0% | Vendida |
US05153U1079 Aura Biosciences Inc | EUR | 0 € | 0% | Vendida |
US31189P1021 Fate Therapeutics In | EUR | 0 € | 0% | Vendida |
US00653A1079 Adaptimmune Therapeu | EUR | 0 € | 0% | Vendida |
US0327241065 AnaptysBio Inc | EUR | 0 € | 0% | Vendida |
US76029N1063 Replimune Group Inc | EUR | 0 € | 0% | Vendida |
US05280R1005 Autolus Therapeutics | EUR | 0 € | 0% | Vendida |
US45175G1085 Ikena Oncology Inc | EUR | 0 € | 0% | Vendida |
US09077A1060 Biomea Fusion Inc | EUR | 0 € | 0% | Vendida |
NL0010872420 Affimed NV | EUR | 0 € | 0% | Vendida |
US0887861088 Bicycle Therapeutics | EUR | 0 € | 0% | Vendida |
US0327973006 Anavex Life Sciences | EUR | 0 € | 0% | Vendida |
CH0499880968 ADC Therapeutics SA | EUR | 0 € | 0% | Vendida |
US45720L1070 Inhibrx Inc | EUR | 0 € | 0% | Vendida |
US00166B1052 ALX Oncology Holding | EUR | 0 € | 0% | Vendida |
US46124U1079 Inventiva SACA | EUR | 0 € | 0% | Vendida |
US46565G1040 iTeos Therapeutics I | EUR | 0 € | 0% | Vendida |
US73730P1084 Poseida Therapeutics | EUR | 0 € | 0% | Vendida |
US14147L1089 Cardiff Oncology Inc | EUR | 0 € | 0% | Vendida |
US7027121000 Passage Bio Inc | EUR | 0 € | 0% | Vendida |
US65487U1088 Nkarta Inc | EUR | 0 € | 0% | Vendida |
US55910K1088 Magenta Therapeutics | EUR | 0 € | 0% | Vendida |
US52490G1022 Legend Biotech Corp | EUR | 0 € | 0% | Vendida |
US45781K2042 Innate Pharma SA | EUR | 0 € | 0% | Vendida |
US3441741077 Foghorn Therapeutics | EUR | 0 € | 0% | Vendida |
US45665G3039 Infinity Pharmaceuti | EUR | 0 € | 0% | Vendida |
US09075P1057 Bioxcel Therapeutics | EUR | 0 € | 0% | Vendida |
US09077B1044 BioAtla Inc | EUR | 0 € | 0% | Vendida |
US75943R1023 Relay Therapeutics I | EUR | 0 € | 0% | Vendida |
US00461U1051 Aclaris Therapeutics | EUR | 0 € | 0% | Vendida |
US04016X1019 ARGENX SE | EUR | 0 € | 0% | Vendida |
US0197701065 AllogeneTherapeutics | EUR | 0 € | 0% | Vendida |
US09609G1004 Bluebird Bio Inc | EUR | 0 € | 0% | Vendida |
US81181C1045 Seattle Genetics Inc | EUR | 0 € | 0% | Vendida |
US03969F1093 Arcus Biosciences In | EUR | 0 € | 0% | Vendida |
US1894641000 Clovis Oncology Inc | EUR | 0 € | 0% | Vendida |
DE0006632003 Morphosys AG | EUR | 0 € | 0% | Vendida |
US8006771062 Sangamo Therapeutics | EUR | 0 € | 0% | Vendida |
NL0010696654 Uni-Pixel Inc. | EUR | 0 € | 0% | Vendida |
US45337C1027 IncytCor | EUR | 0 € | 0% | Vendida |
US28106W1036 Edit-Me | EUR | 0 € | 0% | Vendida |
US4523271090 Illumina Inc | EUR | 0 € | 0% | Vendida |
Cartera ICC
Activo | Div. | Valor | Peso | Dif. |
---|---|---|---|---|
IE00BQ70R696 Invesco NASDAQ Biote | EUR | 0 € | 0% | Vendida |
2023-Q4
Renta Variable Internacional
EUR
457.247,69
15
0
100000
2.922.986 €
6,39 €
Política de Inversión
Operativa con derivados
Sectores
- Salud
96.43%
- No Clasificado
3.57%
Regiones
- Estados Unidos
94.92%
- Europa
5.08%
Tipo de Inversión
- Small Cap - Growth
24.00%
- Small Cap - Value
18.99%
- Small Cap - Blend
12.42%
- Large Cap - Growth
10.39%
- Large Cap - Blend
9.69%
- Medium Cap - Growth
8.76%
- Medium Cap - Value
3.41%
- Medium Cap - Blend
2.97%
- Large Cap - Value
2.77%
- No Clasificado
6.60%
Comisiones
Comisión de gestión
0.50
0.25
Patrimonio
Comisión de depositario
0.08
0.04
Gastos
Acumulado
0.85
Trimestral
0.20
0.26
0.20
0.19
Anual
1.09
0.41